Little progress has been made in identifying effective agents for patients who don't respond to existing ADHD medications.
These results may be used to improve early identification of at-risk siblings based on a proband diagnosis of ADHD.
Recognizing the increased risk for mood disorders in children with ASD and ADHD may be useful for clinicians and parents in developing proper screening and treatment strategies.
If replicated, the novel findings in this study may have important implications for assessing sluggish cognitive tempo in ADHD.
Investigators sought to determine the risk for developing secondary ADHD 5 to 10 years after traumatic brain injury in children and adolescents.
Abstinence relieves symptoms associated with attention-deficit/hyperactivity disorder among patients with polysubstance use disorder.
Clinician awareness of this issue is essential in order to continue providing effective treatment while attempting to reduce abuse of these prescription drugs.
Researchers believe that the large increases in clinical ADHD diagnoses were unlikely to be representative of a real bump in prevalence.
These results may mitigate concerns by physicians regarding the pharmacological treatment of individuals with ADHD.
Contrary to our expectation and the hypotheses put forward by Lulé et al., patients with ALS reported significantly lower rates of self-reported childhood ADHD, no difference in adult ADHD rates, and lower levels of attention deficit symptoms compared to the general population.
Medical costs for children with attention-deficit/hyperactivity disorder have consistently been determined to be higher than for those without the disorder, in part because of the frequency of comorbid conditions such as depression, anxiety, and substance abuse.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- #MeToo: Helping Victims Cope With Sexual Harassment
- Clinician Insight: Exploring the Link Between Bipolar Disorder and Binge Eating Disorder
- Association Between Psychosis and Development of Dementia in Older Men
- Psychosis Could Be a Potential Side Effect of Steroid Treatment in Kids
- Personality Functioning Associated With Global Functioning in Bipolar Disorder I
- Nutritional Influences on Bipolar Disorder in Children
- Triiodothyronine in the Treatment of Bipolar Depression
- Old Challenges and New Directions in Managing Tardive Dyskinesia
- Similar Rates of Childhood Trauma in Schizophrenia and Substance Use Disorders
- Potential for SERMs as Adjunctive Therapy for Schizophrenia
- Childhood Insulin Resistance Associated With Later Psychosis
- Lamotrigine Similar to Placebo in Treating Borderline Personality Disorder
- Glucocorticoids May Increase Risk of Developing Schizophrenia Spectrum Disorder
- Predictors, Incidence of Long-term Use of Benzodiazepines, Z-Drugs in Bipolar Disorder
- Cardiometabolic Dysregulation Associated With Cognitive Decline Mediated by Depression